معرفی
Mitermayer Reis is an Adjunct Professor of Epidemiology (Microbial Diseases) at the Yale School of Public Health, alongside his roles as a Full Professor at the Federal University of Bahia and the Bahian School of Medicine and Public Health. He is a leading researcher at the Oswaldo Cruz Foundation (as a CNPq Category 1A researcher), heads the Laboratory of Pathology and Molecular Biology, and coordinates the Postgraduate Course in Biotechnology in Health and Investigative Medicine. His work focuses on clinical and molecular epidemiology of parasitic and infectious diseases, including arboviruses, Chagas disease, leptospirosis, and bacterial meningitis.
Education:
- Medical Degree: Bahia School of Medicine and Public Health (1979)
- Master's in Human Pathology: Federal University of Bahia (1986)
- PhD in Human Pathology: Federal University of Bahia (1993)
- Postdoctoral Work: Case Western Reserve University and Harvard School of Public Health
Research Interests:
His research emphasizes technological development for infectious disease control, with a focus on arboviruses (e.g., Zika, Chikungunya), Chagas disease, schistosomiasis, and bacterial infections. He investigates immunopathogenesis mechanisms, transmission dynamics, and public health interventions to combat these diseases in resource-constrained settings.
Publications:
Recent work includes studies on SARS-CoV-2 transmission in high-prevalence areas, tick-borne flavivirus neutralizing antibodies, and leptospirosis seroprevalence. His research also explores diagnostic methods for viral pathogens and the impact of vaccines on pneumococcal disease.
Affiliations & Leadership:
- President of the Brazilian Society of Tropical Medicine
- Executive Coordinator of the Northeast Network of Biotechnology (RENORBIO)
- Member of the Academy of Sciences of Bahia and Academy of Medicine of Bahia
- Former Director of the Oswaldo Cruz Foundation (four terms)
Labs & Teams:
He leads the Laboratory of Pathology and Molecular Biology, advancing molecular diagnostics and epidemiological studies of infectious diseases. His work bridges clinical, molecular, and public health approaches to combat tropical and emerging infections.
